1. Home
  2. KRP vs ARDX Comparison

KRP vs ARDX Comparison

Compare KRP & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kimbell Royalty Partners

KRP

Kimbell Royalty Partners

HOLD

Current Price

$14.96

Market Cap

1.4B

Sector

Energy

ML Signal

HOLD

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

HOLD

Current Price

$5.04

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KRP
ARDX
Founded
2013
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.3B
IPO Year
2017
2014

Fundamental Metrics

Financial Performance
Metric
KRP
ARDX
Price
$14.96
$5.04
Analyst Decision
Buy
Strong Buy
Analyst Count
3
7
Target Price
$17.33
$15.14
AVG Volume (30 Days)
525.3K
4.2M
Earning Date
05-07-2026
04-30-2026
Dividend Yield
10.25%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$333,830,000.00
$2,607,000.00
Revenue This Year
$6.88
$37.75
Revenue Next Year
N/A
$34.24
P/E Ratio
N/A
N/A
Revenue Growth
7.93
N/A
52 Week Low
$11.31
$4.08
52 Week High
$15.80
$8.40

Technical Indicators

Market Signals
Indicator
KRP
ARDX
Relative Strength Index (RSI) 52.68 36.58
Support Level $13.96 $4.95
Resistance Level $15.73 $5.34
Average True Range (ATR) 0.28 0.19
MACD 0.05 0.00
Stochastic Oscillator 56.74 9.49

Price Performance

Historical Comparison
KRP
ARDX

About KRP Kimbell Royalty Partners

Kimbell Royalty Partners LP owns and acquires mineral and royalty interests in oil and natural gas properties throughout the United States. The company's basins and producing regions include areas of interest in the Permian Basin, Mid-Continent, Terryville/Cotton Valley/Haynesville, Appalachian Basin, Eagle Ford, Bakken/Williston Basin, and DJ Basin/Rockies/Niobrara. Its revenues are derived from royalty payments received from operators based on the sale of oil, natural gas and NGL production, as well as the sale of NGLs that are extracted from natural gas during processing.

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

Share on Social Networks: